CD34 and graft versus host disease: Among these, a multicenter prospective study of 932 recipients of unrelated donor peripheral blood stem cells (PBSCs) found higher doses of CD34+ cells resulted in rapid engraftment and improved OS without increased risk of graft-versus-host disease (GVHD) [21].